Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Nu-Med Plus (NUMD) Interest Expenses (2016 - 2020)

Nu-Med Plus' Interest Expenses history spans 9 years, with the latest figure at $2214.0 for Q4 2020.

  • Quarterly results put Interest Expenses at $2214.0 for Q4 2020, down 47.0% from a year ago — trailing twelve months through Sep 2021 was $2214.0 (down 86.4% YoY), and the annual figure for FY2025 was $7227.0, up 44.14%.
  • Interest Expenses for Q4 2020 was $2214.0 at Nu-Med Plus, down from $4066.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $4363.0 in Q3 2019 to a low of -$5559.0 in Q3 2016.
  • The 5-year median for Interest Expenses is -$4613.5 (2017), against an average of -$2018.7.
  • The sharpest move saw Interest Expenses tumbled 833.14% in 2017, then soared 191.41% in 2020.
  • Year by year, Interest Expenses stood at $682.0 in 2016, then tumbled by 833.14% to -$5000.0 in 2017, then increased by 0.16% to -$4992.0 in 2018, then skyrocketed by 183.67% to $4177.0 in 2019, then crashed by 47.0% to $2214.0 in 2020.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $2214.0, $4066.0, and $4021.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.